- Home
- ONVO vs SNES Comparison
ONVO vs SNES Comparison
Compare ONVO & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONVO
- SNES
- Stock Information
- Founded
- ONVO 2007
- SNES 2004
- Country
- ONVO United States
- SNES United States
- Employees
- ONVO N/A
- SNES N/A
- Industry
- ONVO Biotechnology: Biological Products (No Diagnostic Substances)
- SNES Agricultural Chemicals
- Sector
- ONVO Health Care
- SNES Industrials
- Exchange
- ONVO Nasdaq
- SNES Nasdaq
- Market Cap
- ONVO 3.0M
- SNES 2.9M
- IPO Year
- ONVO N/A
- SNES 2016
- Fundamental
- Price
- ONVO $1.87
- SNES $2.27
- Analyst Decision
- ONVO
- SNES Strong Buy
- Analyst Count
- ONVO 0
- SNES 1
- Target Price
- ONVO N/A
- SNES $10.00
- AVG Volume (30 Days)
- ONVO 347.1K
- SNES 44.4K
- Earning Date
- ONVO 05-30-2025
- SNES 05-08-2025
- Dividend Yield
- ONVO N/A
- SNES N/A
- EPS Growth
- ONVO N/A
- SNES N/A
- EPS
- ONVO N/A
- SNES N/A
- Revenue
- ONVO $122,000.00
- SNES $1,857,000.00
- Revenue This Year
- ONVO $59.08
- SNES $130.53
- Revenue Next Year
- ONVO $18.24
- SNES $80.00
- P/E Ratio
- ONVO N/A
- SNES N/A
- Revenue Growth
- ONVO N/A
- SNES 55.66
- 52 Week Low
- ONVO $1.56
- SNES $1.30
- 52 Week High
- ONVO $21.96
- SNES $9.80
- Technical
- Relative Strength Index (RSI)
- ONVO 37.84
- SNES 58.80
- Support Level
- ONVO $1.56
- SNES $1.77
- Resistance Level
- ONVO $1.78
- SNES $2.16
- Average True Range (ATR)
- ONVO 0.24
- SNES 0.22
- MACD
- ONVO 0.13
- SNES 0.10
- Stochastic Oscillator
- ONVO 43.06
- SNES 100.00
About ONVO Organovo Holdings Inc.
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.